A single misbehaving protein — called TDP-43 — is behind 97 percent of amyotrophic lateral sclerosis (ALS) cases and 45
Read more
An existing drug may have therapeutic potential in mitochondrial disease: Animal studies may offer clues to possible precision medicine approach
New preclinical findings from extensive cell and animal studies suggest that a drug already used for a rare kidney disease
Read more
Birch pollen allergen immunotherapy normalizes nasal gene-expression and microbial community
Birch pollen allergic rhinitis is the most common chronic disorder in the Northern part of the globe, and it attributes
Read more
Time-lapse microscopy helps reveal brake mechanism in Streptomyces lifecycle
Streptomyces are soil-dwelling bacteria that produce approximately two-thirds of the antibiotics in current clinical use. The production of these antibiotics
Read more
A match made in neural heaven: How a neuron grows an axon: Scientists unlock new molecular secrets to unravel the mystery
While the neural architecture responsible for the transmission of electrical impulses has been known for more than a century, the
Read more
A new toolkit for studying how ‘PARP’ activity boosts cancers
A new method developed by scientists at Johns Hopkins Bloomberg School of Public Health is likely to speed the study
Read more
A closed cage-like molecule that can be opened
Molecular cages offer the possibility to encapsulate ions or other molecules. If the cage structure has a ‘hatch’ that can
Read more
New insight into unique sugar transport in plants
Sugar transport through Sugar Transport Proteins (STP) is unique to plants, and is important for the proper development of plant
Read more
Differences among brain neurons that coincide with psychiatric conditions
It’s no surprise to scientists that variety is the very essence of biology, not just the seasoning, but most previous
Read more
Using genetics of human fat cells to predict response to anti-diabetes drugs: Study shows that individual genetic variation affects which meds to take
Drugs called thiazolidinediones (TZDs) reverse insulin resistance in patients with type 2 diabetes by targeting the activity of a receptor
Read more